Mechanical stress may affect normal bone development

The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...

January 21, 2019 | Monday | News
Thyas signs a licensing agreement with iPS-AJ

Thyas has signed a licensing agreement with iPS Academia Japan, Inc. (iPS-AJ), a technology licensing organization of in...

January 18, 2019 | Friday | News
J&J completes acquisition of Ci:z Holdings

Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase pr...

January 18, 2019 | Friday | News
AIVITA gets IND nod for Phase 1B melanoma trial

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...

January 17, 2019 | Thursday | News
Daiichi Sankyo to lead open innovation research on cell therapy

Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Tokyo Institute of Technology have announced that ...

January 11, 2019 | Friday | News
Japan approves Amgen's osteoporosis drug

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...

January 10, 2019 | Thursday | News
Daiichi Sankyo receives regulatory approval for hypertension tablets

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...

January 10, 2019 | Thursday | News
NapaJen Pharma closes $12.4M Series C financing

NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery...

January 9, 2019 | Wednesday | News
Takeda completes acquisition of Shire

Takeda Pharmaceutical Company Limited (“Takeda”) announced the completion of its acquisition of Shire plc (&...

January 8, 2019 | Tuesday | News
Fujifilm to invest 10B Yen in Bio CDMO biz

FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in ...

January 8, 2019 | Tuesday | News
Solasia initiates Phase III programme for PledOx

Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...

January 7, 2019 | Monday | News
Otsuka, Click Therapeutics to create therapy for mental illness

Otsuka Pharmaceutical Co., Ltd. announces that its U.S. holding company subsidiary Otsuka America, Inc, and Click Therap...

January 7, 2019 | Monday | News
Takeda announces multiple cell therapy collaborations

Takeda Pharmaceutical  has announced new research collaborations in immuno-oncology (I-O), an area of key strategic...

January 4, 2019 | Friday | News
Researchers discover laminin which can convert stem cells into retinal-like cells

Researchers from Osaka University in Japan have discovered a way to convert human pluripotent stem cells into various ce...

January 2, 2019 | Wednesday | News
MediPharm Labs declares its addition to HMMJ Index

MediPharm Labs Corp., a specialized, research-driven cannabis extraction business licensed under the Cannabis Act, is pl...

December 31, 2018 | Monday | News
Taisho Pharmaceutical Holdings to purchase BMS's UPSA

Bristol-Myers Squibb Company recently announced that Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myer...

December 30, 2018 | Sunday | News
Prevelance of colistin-resistance high in Vietnam: Research

A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents ...

December 28, 2018 | Friday | News
Chugai obtains approval for Genomic Mutation Analysis Program

Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...

December 27, 2018 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls